Latest Us Market News

Adveritas Limited’s annualised recurring revenue (ARR) has surged to $16.3 million, driven by rapid organic growth of its SME self-serve platform and expanding North American footprint beyond gaming.

Energy Transition Minerals (ASX: ETM) has appointed Alexander B. Gray, a former senior US national security official, to its Strategic Advisory Board, enhancing its geopolitical clout and US engagement as it pushes forward with its Greenland rare earths project.

Pacific Edge reported a steep 47% revenue drop in FY26 following Medicare coverage loss but secured a draft Medicare policy covering its Cxbladder tests and raised NZ$25.4 million to fuel growth and commercial execution.

PainChek has secured A$5.5 million via convertible notes to accelerate its US sales expansion and strengthen working capital amid key commercial milestones.

Guzman y Gomez has abruptly exited the US market, citing financial underperformance despite brand progress, while reaffirming strong Australian growth and international franchise confidence.

Vitrafy Life Sciences has achieved a major validation milestone with US Army-backed Phase II results showing its no-wash platelet cryopreservation protocol delivers 94% post-thaw recovery, outperforming existing standards and advancing FDA registration plans.

AFT Pharmaceuticals posted a 22% revenue jump to NZ$254.7 million and a 39% increase in operating profit to a record NZ$24.4 million for FY26, exceeding guidance. The company targets over NZ$300 million revenue for FY27, fueled by international expansion and a deepening R&D pipeline.

OD6 Metals is progressing its acquisition option for the Quinn Fluorspar Project in Nevada, a high-grade fluorspar asset poised to address the United States' complete import reliance on this critical mineral vital to semiconductor, battery, and defense sectors.

Ovanti Limited is proposing to issue over 520 million free-attaching options to recent placement investors and its lead manager, exercisable at $0.025 and expiring in 2030, pending shareholder approval.

EBR Systems has locked in a three-year purchasing agreement with CHRISTUS Health, the ninth-largest US hospital network, to advance its WiSE CRT System's US rollout across 66 hospitals.

Serko Limited posted a 34% jump in total income to NZD 120.9 million for FY26, powered by strong Booking.com for Business growth and a full year of GetThere revenue. The company’s EBITDAFI surged 137%, while net loss narrowed. Serko.ai’s US closed beta marks a strategic pivot into AI-driven business travel.

American Tungsten & Antimony Ltd (ASX: AT4) has raised A$10 million through a strongly supported placement and secured a 40% Utah state tax credit, underpinning its strategy to develop a domestic US supply chain for tungsten and antimony ahead of a planned Nasdaq listing.